Mission and Objectives

Our Mission

The mission of the PC-TRiADD Centre of Excellence for Commercialization and Research is to serve as a hybrid between academic research and the biotechnology industry to foster team-driven translational health research. Our aim is to discover how prostate cancer progresses and why it resists therapies and use this information to develop new services and products to improve cancer outcomes and promote regional growth of biotechnology.

Our Objectives

  1. Accelerate discovery, development, and commercialization of anti-cancer therapeutics
  2. Improve our recruitment, training and retention of Highly Qualified Personnel to fuel the biotechnology industry in BC and in Canada
  3. Achieve long-term operational sustainability by generating intellectual property

News

Jul 26 2017

Dr. Zoubeidi awarded PCC-Movember Translation Acceleration Grant

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.

Read more